GLOBUS MEDICAL, INC. Selling, General and Administrative Expense
GLOBUS MEDICAL, INC. (GMED) reported Selling, General and Administrative Expense of $286.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- GLOBUS MEDICAL, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $286.82M, a 5.53% decline year-over-year.
- GLOBUS MEDICAL, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $297.77M, a 22.64% increase year-over-year.
- GLOBUS MEDICAL, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $318.48M, a 25.80% increase year-over-year.
- GLOBUS MEDICAL, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $313.60M, a 30.63% increase year-over-year.
- GLOBUS MEDICAL, INC. selling, general and administrative expense for fiscal 2025 was $1.18B, a 20.09% increase from fiscal 2024.
- GLOBUS MEDICAL, INC. selling, general and administrative expense for fiscal 2024 was $981.36M, a 52.42% increase from fiscal 2023.
- GLOBUS MEDICAL, INC. selling, general and administrative expense for fiscal 2023 was $643.84M, a 49.00% increase from fiscal 2022.
- GLOBUS MEDICAL, INC. selling, general and administrative expense for fiscal 2022 was $432.12M, a 5.87% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $286.82M 10-Q · filed 2026-08-06 | $584.60M 10-Q · filed 2026-08-06 | $903.08M derived: sum of 3 quarters · filed 2026-08-06 | $1.22B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $297.77M 10-Q · filed 2026-05-07 | $616.25M derived: sum of 2 quarters · filed 2026-05-07 | $929.85M derived: sum of 3 quarters · filed 2026-05-07 | $1.23B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $318.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $632.08M derived: sum of 2 quarters · filed 2026-02-24 | $935.70M derived: sum of 3 quarters · filed 2026-08-06 | $1.18B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $313.60M 10-Q · filed 2025-11-06 | $617.22M derived: sum of 2 quarters · filed 2026-08-06 | $860.02M 10-Q · filed 2025-11-06 | $1.11B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $303.62M 10-Q · filed 2026-08-06 | $546.42M 10-Q · filed 2026-08-06 | $799.59M derived: sum of 3 quarters · filed 2026-08-06 | $1.04B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $242.80M 10-Q · filed 2026-05-07 | $495.97M derived: sum of 2 quarters · filed 2026-05-07 | $736.03M derived: sum of 3 quarters · filed 2026-05-07 | $975.48M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $253.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $493.23M derived: sum of 2 quarters · filed 2026-02-24 | $732.68M derived: sum of 3 quarters · filed 2026-02-24 | $981.36M 10-K · filed 2026-02-24 | $981.05M 10-K · filed 2025-02-20 | |||
| 2024-09-30 | $240.06M 10-Q · filed 2025-11-06 | $240.74M 10-Q · filed 2024-11-05 | $479.52M derived: sum of 2 quarters · filed 2025-11-06 | $728.20M 10-Q · filed 2025-11-06 | $727.57M 10-Q · filed 2024-11-05 | $973.35M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $239.45M 10-Q · filed 2025-08-07 | $238.12M 10-Q · filed 2024-08-06 | $488.13M 10-Q · filed 2025-08-07 | $486.83M 10-Q · filed 2024-08-06 | $733.29M derived: sum of 3 quarters · filed 2026-02-24 | $889.49M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $248.68M 10-Q · filed 2025-05-08 | $248.71M 10-Q · filed 2024-05-07 | $493.83M derived: sum of 2 quarters · filed 2026-02-24 | $650.04M derived: sum of 3 quarters · filed 2026-02-24 | $770.11M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | $245.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $401.36M derived: sum of 2 quarters · filed 2026-02-24 | $521.43M derived: sum of 3 quarters · filed 2026-02-24 | $643.84M 10-K · filed 2026-02-24 | $643.41M 10-K · filed 2024-02-21 | |||
| 2023-09-30 | $156.21M 10-Q · filed 2024-11-05 | $276.27M derived: sum of 2 quarters · filed 2024-11-05 | $398.69M 10-Q · filed 2024-11-05 | $516.77M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $120.07M 10-Q · filed 2024-08-06 | $242.49M 10-Q · filed 2024-08-06 | $360.56M derived: sum of 3 quarters · filed 2025-02-20 | $467.14M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $122.42M 10-Q · filed 2024-05-07 | $240.49M derived: sum of 2 quarters · filed 2025-02-20 | $347.07M derived: sum of 3 quarters · filed 2025-02-20 | $453.79M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $118.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $224.65M derived: sum of 2 quarters · filed 2025-02-20 | $331.37M derived: sum of 3 quarters · filed 2025-02-20 | $432.12M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $106.58M 10-Q · filed 2023-11-07 | $213.29M derived: sum of 2 quarters · filed 2023-11-07 | $314.04M 10-Q · filed 2023-11-07 | $420.60M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $106.72M 10-Q · filed 2023-08-03 | $207.47M 10-Q · filed 2023-08-03 | $314.03M derived: sum of 3 quarters · filed 2024-02-21 | $410.47M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $100.75M 10-Q · filed 2023-05-04 | $207.31M derived: sum of 2 quarters · filed 2024-02-21 | $303.75M derived: sum of 3 quarters · filed 2024-02-21 | $411.01M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $106.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $203.00M derived: sum of 2 quarters · filed 2024-02-21 | $310.26M derived: sum of 3 quarters · filed 2024-02-21 | $408.15M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $96.44M 10-Q · filed 2022-11-08 | $203.70M derived: sum of 2 quarters · filed 2022-11-08 | $301.59M 10-Q · filed 2022-11-08 | $393.64M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $107.25M 10-Q · filed 2022-08-04 | $205.15M 10-Q · filed 2022-08-04 | $297.19M derived: sum of 3 quarters · filed 2023-02-21 | $386.34M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $97.89M 10-Q · filed 2022-05-10 | $189.94M derived: sum of 2 quarters · filed 2023-02-21 | $279.09M derived: sum of 3 quarters · filed 2023-02-21 | $359.11M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $92.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $181.20M derived: sum of 2 quarters · filed 2023-02-21 | $261.22M derived: sum of 3 quarters · filed 2023-02-21 | $354.76M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $89.15M 10-Q · filed 2021-11-04 | $169.17M derived: sum of 2 quarters · filed 2021-11-04 | $262.71M 10-Q · filed 2021-11-04 | $354.85M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-30 | $80.02M 10-Q · filed 2021-08-04 | $173.56M 10-Q · filed 2021-08-04 | $265.70M derived: sum of 3 quarters · filed 2022-02-17 | $354.15M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | $93.54M 10-Q · filed 2021-05-04 | $185.68M derived: sum of 2 quarters · filed 2022-02-17 | $274.13M derived: sum of 3 quarters · filed 2022-02-17 | $362.51M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-31 | $92.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $180.59M derived: sum of 2 quarters · filed 2022-02-17 | $268.97M derived: sum of 3 quarters · filed 2022-02-17 | $354.76M 10-K · filed 2022-02-17 | ||||
| 2019-09-30 | $88.45M 10-Q · filed 2020-10-28 | $176.83M derived: sum of 2 quarters · filed 2020-10-28 | $262.62M 10-Q · filed 2020-10-28 | $262.62M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | $88.38M 10-Q · filed 2020-08-05 | $174.16M 10-Q · filed 2020-08-05 | $174.16M derived: sum of 3 quarters · filed 2021-02-17 | $249.29M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $85.78M 10-Q · filed 2020-05-07 | $85.78M derived: sum of 2 quarters · filed 2021-02-17 | $160.91M derived: sum of 3 quarters · filed 2021-02-17 | $238.04M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17 | $75.13M derived: sum of 2 quarters · filed 2021-02-17 | $152.26M derived: sum of 3 quarters · filed 2021-02-17 | $311.59M 10-K · filed 2021-02-17 | ||||
| 2018-09-30 | $75.13M 10-Q · filed 2019-11-06 | $152.26M derived: sum of 2 quarters · filed 2019-11-06 | $311.59M 10-K · filed 2020-02-20 | $227.95M 10-Q · filed 2018-11-08 | $300.91M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $77.13M 10-Q · filed 2019-08-01 | $152.82M 10-Q · filed 2019-08-01 | $225.78M derived: sum of 3 quarters · filed 2020-03-02 | $289.14M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $75.69M 10-Q · filed 2019-05-02 | $148.65M derived: sum of 2 quarters · filed 2020-03-02 | $212.01M derived: sum of 3 quarters · filed 2020-03-02 | $276.45M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $72.96M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $136.32M derived: sum of 2 quarters · filed 2020-03-02 | $200.76M derived: sum of 3 quarters · filed 2020-03-02 | $267.82M 10-K/A · filed 2020-03-02 | ||||
| 2017-09-30 | $63.36M 10-Q · filed 2018-11-08 | $127.80M derived: sum of 2 quarters · filed 2018-11-08 | $194.86M 10-Q · filed 2018-11-08 | $255.70M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-06-30 | $64.44M 10-Q · filed 2018-08-02 | $131.50M 10-Q · filed 2018-08-02 | $192.34M derived: sum of 3 quarters · filed 2019-02-21 | $246.54M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-03-31 | $67.06M 10-Q · filed 2018-05-03 | $127.90M derived: sum of 2 quarters · filed 2019-02-21 | $182.10M derived: sum of 3 quarters · filed 2019-02-21 | $235.42M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2016-12-31 | $60.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $115.05M derived: sum of 2 quarters · filed 2019-02-21 | $168.36M derived: sum of 3 quarters · filed 2019-02-21 | $222.16M 10-K · filed 2019-02-21 | ||||
| 2016-09-30 | $54.21M 10-Q · filed 2017-11-09 | $107.52M derived: sum of 2 quarters · filed 2017-11-09 | $161.32M 10-Q · filed 2017-11-09 | $214.12M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $53.31M 10-Q · filed 2017-08-03 | $52.41M 10-Q · filed 2016-07-27 | $107.11M 10-Q · filed 2017-08-03 | $106.98M 10-Q · filed 2016-07-27 | $159.91M derived: sum of 3 quarters · filed 2018-02-22 | $212.08M derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-03-31 | $53.80M 10-Q · filed 2017-05-04 | $54.57M 10-Q · filed 2016-05-04 | $106.60M derived: sum of 2 quarters · filed 2018-02-22 | $158.77M derived: sum of 3 quarters · filed 2018-02-22 | $213.28M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $52.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $104.97M derived: sum of 2 quarters · filed 2018-02-22 | $159.48M derived: sum of 3 quarters · filed 2018-02-22 | $210.24M 10-K · filed 2018-02-22 | $214.01M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $52.17M 10-Q · filed 2016-11-09 | $53.83M 10-Q · filed 2015-11-04 | $106.68M derived: sum of 2 quarters · filed 2016-11-09 | $157.44M 10-Q · filed 2016-11-09 | $160.62M 10-Q · filed 2015-11-04 | $207.51M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $54.51M 10-Q · filed 2016-07-27 | $106.80M 10-Q · filed 2016-07-27 | $155.34M derived: sum of 3 quarters · filed 2017-03-16 | $202.32M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $52.29M 10-Q · filed 2016-05-04 | $100.83M derived: sum of 2 quarters · filed 2017-03-16 | $147.82M derived: sum of 3 quarters · filed 2017-03-16 | $194.24M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $48.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $95.53M derived: sum of 2 quarters · filed 2017-03-16 | $141.95M derived: sum of 3 quarters · filed 2017-03-16 | $188.63M 10-K · filed 2017-03-16 | $187.80M 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $46.99M 10-Q · filed 2015-11-04 | $93.41M derived: sum of 2 quarters · filed 2015-11-04 | $140.09M 10-Q · filed 2015-11-04 | $185.76M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $46.42M 10-Q · filed 2015-07-31 | $93.10M 10-Q · filed 2015-07-31 | $138.77M derived: sum of 3 quarters · filed 2016-02-29 | $184.47M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $46.68M 10-Q · filed 2015-05-05 | $92.35M derived: sum of 2 quarters · filed 2016-02-29 | $138.05M derived: sum of 3 quarters · filed 2016-02-29 | $183.80M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $45.67M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $91.37M derived: sum of 2 quarters · filed 2016-02-29 | $137.12M derived: sum of 3 quarters · filed 2016-02-29 | $182.52M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $45.70M 10-Q · filed 2014-10-31 | $91.45M derived: sum of 2 quarters · filed 2014-10-31 | $136.85M 10-Q · filed 2014-10-31 | $181.47M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $45.75M 10-Q · filed 2014-08-06 | $91.15M 10-Q · filed 2014-08-06 | $135.77M derived: sum of 3 quarters · filed 2015-02-26 | $177.55M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $45.40M 10-Q · filed 2014-04-30 | $90.02M derived: sum of 2 quarters · filed 2015-02-26 | $131.80M derived: sum of 3 quarters · filed 2015-02-26 | $173.03M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $44.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $86.41M derived: sum of 2 quarters · filed 2015-02-26 | $127.64M derived: sum of 3 quarters · filed 2015-02-26 | $168.86M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $41.78M 10-Q · filed 2013-10-31 | $83.01M derived: sum of 2 quarters · filed 2013-10-31 | $124.24M 10-Q · filed 2013-10-31 | $162.09M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $41.23M 10-Q · filed 2013-08-02 | $82.46M 10-Q · filed 2013-08-02 | $120.31M derived: sum of 3 quarters · filed 2014-03-14 | $155.07M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $41.23M 10-Q · filed 2013-05-03 | $79.08M derived: sum of 2 quarters · filed 2014-03-14 | $113.84M derived: sum of 3 quarters · filed 2014-03-14 | $147.60M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $37.86M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $72.62M derived: sum of 2 quarters · filed 2014-03-14 | $106.37M derived: sum of 3 quarters · filed 2014-03-14 | $140.39M 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $34.76M 10-Q · filed 2012-11-02 | $68.52M derived: sum of 2 quarters · filed 2012-11-02 | $102.53M 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $33.75M 10-Q/A · filed 2012-09-19 | $67.77M 10-Q/A · filed 2012-09-19 | ||||||
| 2010-12-31 | $122.59M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |